Stalevo · DIN 02305933 · 50 & 12.5 & 200 mg · tablet
Limited Use, Reason for Use code 367 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 367 required
Write on scriptReason for Use code 367 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 367
Reason for Use code 367
For the treatment of patients with Parkinson's disease with 25% of the waking day in the off state despite maximally tolerated doses of levodopa.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Stalevo · DIN 02305933
Manufacturer: Sandoz Canada Inc.; listing date 2009-03-02
Health Canada: Marketed since 2020-07-24 · brand STALEVO · ATC N04BA03 LEVODOPA,DECARBOXYLASE INHIBITOR, AND COMT INHIBITOR · form Tablet · route Oral · ingredients LEVODOPA 50 MG, CARBIDOPA 12.5 MG, ENTACAPONE 200 MG · company Sandoz canada incorporated · schedule Prescription
Stalevo: Formulary list price $1.75 per unit (the source does not state the unit; exact figure $1.7471). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02305933)
Source record
DIN 02305933: Stalevo
Raw flags: sec12=Y, sec3=Y
Item: 920000588; group id 933; item number 2226; lccId 00199; manufacturer id SDZ
Source form: Tab; strength: 50 & 12.5 & 200mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $1.7471; ministry $1.7471
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02305933
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79150
Shortage status: not checked (no credentials)